Written by the Nuvirox Research Team
Key points
- Topical niacinamide (a NAD+ precursor) has real randomized-trial support for improving rosacea-adjacent skin barrier function and reducing redness, dryness, and inflammatory lesions.
- That evidence is almost entirely for topical niacinamide in moisturizers, not oral NAD+ precursor supplements like NR — the route matters.
- Rosacea has no cure, and moderate-to-severe cases still need a dermatologist; niacinamide research supports it as an adjunct, not a replacement, for standard treatment.
Short answer: yes, with an important asterisk. Niacinamide — the amide form of vitamin B3 and a direct precursor to NAD+ — has decent human evidence for calming rosacea-related redness and barrier dysfunction. But nearly all of that evidence comes from niacinamide applied to the skin, not swallowed as an oral NAD+ supplement. If you're dealing with rosacea, that distinction changes what you should actually expect from any given product.
What is the actual connection between NAD+ and rosacea?
Every cell in your skin, including keratinocytes and the immune cells that drive rosacea's characteristic flushing and inflammation, relies on NAD+ to run its energy metabolism and DNA repair machinery. Niacinamide is one of the most direct ways to feed that NAD+ pool. Topically, niacinamide has been shown to strengthen the skin's stratum corneum barrier, calm inflammatory cytokine signaling (IL-1, IL-6, TNF-alpha), and improve hydration — all relevant to rosacea, where barrier dysfunction and low-grade inflammation are core features.
What does the human evidence actually show?
The clearest trial: a randomized, investigator-blind study of 50 rosacea patients tested a niacinamide-containing facial moisturizer applied twice daily for four weeks (Draelos et al., Cutis, 2005). It found measurable improvements in stratum corneum barrier function and hydration, along with a "marked decrease in erythema severity" and reduced dryness and scaling over the treatment period.
Study snapshot: Niacinamide moisturizer in rosacea (Draelos 2005)
| Design | Randomized, investigator-blind, controlled |
| N | 50 rosacea patients |
| Duration | 4 weeks, twice-daily application |
| Route | Topical facial moisturizer |
| Finding | Improved barrier function, reduced erythema, dryness, and scaling |
Separately, dermatology reviews note that pharmacologic-dose oral nicotinamide has been used off-label for other inflammatory skin conditions, and the 2015 ONTRAC trial established that oral nicotinamide (500 mg twice daily) safely reduces skin cancer incidence in high-risk patients — useful safety data, but not a rosacea efficacy trial.
The honest counterweight
Here's what's missing: there is no published randomized trial of an oral NAD+ precursor (NR, NMN, or straight nicotinamide) specifically for rosacea. The strongest data point is a single, small, 20-year-old topical trial with a moisturizer formulation, not an isolated ingredient. It also didn't compare niacinamide against an active rosacea treatment like topical ivermectin or azelaic acid, so we don't know how it stacks up. Extrapolating "niacinamide helps skin barrier" to "an oral NAD+ capsule will calm your rosacea" is a bigger leap than the evidence supports.
When to see a doctor
Rosacea has no cure and can resemble other conditions (lupus, acne, seborrheic dermatitis). If you have persistent facial redness, visible blood vessels, or eye irritation, see a dermatologist for a proper diagnosis and a treatment plan — topical or oral prescription options have far more direct evidence than any supplement.
What actually helps rosacea, evidence-wise
The best-supported approaches remain prescription topicals (metronidazole, azelaic acid, ivermectin), oral antibiotics for inflammatory subtypes, laser therapy for visible vessels, and consistent trigger avoidance (sun, heat, alcohol, spicy food, certain skincare ingredients). Niacinamide-containing moisturizers are a reasonable, low-risk adjunct to strengthen the skin barrier alongside those treatments — not a substitute for them.
How does this compare to other rosacea triggers people manage?
Rosacea flares are driven by a mix of vascular reactivity and immune signaling, which is why trigger management (sun, heat, alcohol, certain skincare actives) is usually paired with any topical or oral approach. If you're also dealing with general skin sensitivity or barrier concerns beyond rosacea, it's worth reading about how nicotinamide supplements work more broadly, since niacinamide's barrier and anti-inflammatory effects aren't unique to rosacea — the same mechanisms show up in research on eczema and other inflammatory skin conditions.
It's also worth understanding the dose distinction clearly: the ONTRAC trial that established oral nicotinamide's skin-cancer-prevention benefit used 500 mg twice daily of plain nicotinamide, a much higher and different dosing pattern than what's in a typical NAD+ precursor supplement like NR, which is dosed for cellular energy support rather than dermatologic outcomes. If side effects are a concern with any B3-family supplement, our overview of NAD+ supplement side effects covers what trials have actually reported.
Dosing context also matters here: the trials with the clearest supporting evidence used niacinamide concentrations in the 2%-5% range in topical formulations, applied consistently over weeks, not a single application. If you do try a niacinamide-containing moisturizer for barrier support, give it the same four-week window the Draelos trial used before judging whether it's helping, since skin barrier changes take time to show up.
One more practical distinction worth making: subtype matters. Erythematotelangiectatic rosacea (persistent redness and visible vessels) and papulopustular rosacea (redness plus bumps and pustules) respond differently to different treatments, and the Draelos trial enrolled patients with subtype 1 or 2 specifically. If you have ocular rosacea (eye involvement) or the rhinophyma subtype, niacinamide research doesn't directly address those presentations, and a dermatologist's guidance becomes even more important for picking the right combination of treatments.
Patch-testing any new topical product, including niacinamide moisturizers, on a small area of skin for a few days before full-face use is a reasonable precaution for rosacea-prone skin specifically, since it can be more reactive to new ingredients and formulation changes than average skin.
As with any skincare change, give it a full four-to-six week trial before deciding whether it's making a real difference.
Frequently asked questions
Should I use a niacinamide moisturizer if I have rosacea?
The trial evidence supports it as a barrier-supporting adjunct, and niacinamide is generally well tolerated even on sensitive skin. It's reasonable to try alongside, not instead of, dermatologist-guided treatment.
Will an oral NAD+ supplement help my rosacea?
There's no direct trial evidence for that specific claim. Oral NAD+ precursors are studied for cellular energy and healthy aging broadly, not rosacea.
Is niacinamide the same as niacin?
No. Niacin (nicotinic acid) can cause a flushing reaction that could aggravate rosacea; niacinamide (nicotinamide) does not cause that flush and is the form used in the skin trials discussed here.
From Nuvirox
Why we formulated NAD+ Restore
NAD+ Restore isn't formulated to address this specific condition, but if you're also interested in general cellular energy and healthy-aging support, here's what's in it.
- 500 mg Nicotinamide Riboside Chloride (NR) — one of the two most-researched NAD+ precursors, within the dose range used in published human trials
- 150 mg trans-resveratrol (Japanese Knotweed) + 50 mg quercetin (Sophora japonica) — polyphenols studied alongside NAD+ pathways for cellular health support
- 10 mg galactomannans from fenugreek — to support absorption
- 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should
The bottom line: topical niacinamide has genuine, if limited, trial support for rosacea-related skin barrier symptoms. An oral NAD+ precursor supplement is a different product tested for different outcomes — treat rosacea itself with dermatologist-guided care, and think of general NAD+ support as a separate, unrelated wellness goal.
References
- Draelos ZD, Ertel K, Berge C. Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. Cutis. 2005;76(2):135-141. PMID: 16209160.
- Boo YC. Mechanistic Basis and Clinical Evidence for the Applications of Nicotinamide (Niacinamide) to Control Skin Aging and Pigmentation. Antioxidants. 2021;10(8):1315. PMCID: PMC8389214.
- Chen AC, et al. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention (ONTRAC). N Engl J Med. 2015.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.